Citigroup »

Cerevel Therapeutics Hldng I shares owned by Citigroup

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $24M 572k 42.40
2023-09-30 $1.8M 84k 22.00
2023-03-31 $5.6M 229k 24.39
2022-12-31 $4.8M 153k 31.54
2022-09-30 $3.9M 140k 28.26
2021-12-31 $4.0M 122k 32.42
2021-03-31 $1.4M 104k 13.73
2020-12-31 $1.5M 92k 16.58